These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Characteristics of a protease of Streptococcus sanguis G9B which degrades the major salivary adhesin. Lamont RJ; Rosan B FEMS Microbiol Lett; 1989 Mar; 49(1):101-5. PubMed ID: 2656394 [TBL] [Abstract][Full Text] [Related]
27. Sites in the CH3 domain of human IgA1 that influence sensitivity to bacterial IgA1 proteases. Senior BW; Woof JM J Immunol; 2006 Sep; 177(6):3913-9. PubMed ID: 16951354 [TBL] [Abstract][Full Text] [Related]
28. [Detection of bacterial antigens in cerebrospinal fluid by immunoelectroosmophoresis]. Sillanpää M; Irjala K; Willman K Duodecim; 1975; 91(5):278-82. PubMed ID: 238827 [No Abstract] [Full Text] [Related]
29. Presence of antibodies to Mycoplasma pneumoniae in patients with bacterial meningitis. Lederman MM; Ellner JJ J Infect Dis; 1983 Aug; 148(2):363-5. PubMed ID: 6411835 [No Abstract] [Full Text] [Related]
30. Some aspects of protease production by a strain of Streptococcus sanguis. Rogers AH; Zilm PS; Pfenning AL; Gully NJ Oral Microbiol Immunol; 1990 Apr; 5(2):72-6. PubMed ID: 2087351 [TBL] [Abstract][Full Text] [Related]
32. Counterimmunoelectrophoresis for rapid diagnosis of meningitis due to Diplococcus pneumoniae. Fossieck B; Craig R; Paterson PY J Infect Dis; 1973 Jan; 127(1):106-9. PubMed ID: 4405108 [No Abstract] [Full Text] [Related]
33. Normal immunoglobulin levels in children who have recovered from meningococcal meningitis. Spirer Z; Shalev I; Marcus G; Bogair N Clin Pediatr (Phila); 1974 Aug; 13(8):672-4. PubMed ID: 4217235 [No Abstract] [Full Text] [Related]
34. Cerebrospinal fluid complement activation in patients with pneumococcal and meningococcal meningitis. Mook-Kanamori BB; Brouwer MC; Geldhoff M; Ende Av; van de Beek D J Infect; 2014 Jun; 68(6):542-7. PubMed ID: 24412248 [TBL] [Abstract][Full Text] [Related]
35. MANAGEMENT OF MENINGITIS. ANDERSON JP Br Med J; 1964 May; 1(5393):1310-1. PubMed ID: 14123642 [No Abstract] [Full Text] [Related]
36. AMPICILLIN IN THE TREATMENT OF ACUTE BACTERIAL MENINGITIS. IVLER D; THRUPP LD; LEEDOM JM; WEHRLE PF; PORTNOY B Antimicrob Agents Chemother (Bethesda); 1963; 161():335-45. PubMed ID: 14274920 [No Abstract] [Full Text] [Related]
37. BACTERIAL MENINGITIS--A REVIEW OF SELECTED ASPECTS. II. SPECIAL NEUROLOGIC PROBLEMS, POSTMENINGITIC COMPLACATIONS AND CLINICOPATHOLOGICAL CORRELATIONS. DODGE PR; SWARTZ MN N Engl J Med; 1965 May; 272():954-60 CONTD. PubMed ID: 14275833 [No Abstract] [Full Text] [Related]
38. ANTIBIOTICS FOR ACUTE BACTERIAL MENINGITIS. ROY TE Can Med Assoc J; 1964 Apr; 90(15):931-2. PubMed ID: 14139992 [No Abstract] [Full Text] [Related]
39. MANAGEMENT OF MENINGITIS. ANDERSON T Br Med J; 1964 May; 1(5393):1310. PubMed ID: 14123641 [No Abstract] [Full Text] [Related]
40. [Local immunity and microbial IgA proteases]. Chernokhvostova EV Zh Mikrobiol Epidemiol Immunobiol; 1987 Jun; (6):104-11. PubMed ID: 3307235 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]